Weekly Cumulative Influenza Vaccine Doses Distributed in the United States

Principal Investigator(s):  View help for Principal Investigator(s) United States Department of Health and Human Services. Centers for Disease Control and Prevention; Vaccinations

Version:  View help for Version V1

Name File Type Size Last Modified
Weekly Cumulative Influenza Vaccine Doses Distributed in the United States 0

Project Citation: 

United States Department of Health and Human Services. Centers for Disease Control and Prevention, and Vaccinations. Weekly Cumulative Influenza Vaccine Doses Distributed in the United States. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], 2026-01-12. https://doi.org/10.3886/E243724V1

Project Description

Project Title:  View help for Project Title Weekly Cumulative Influenza Vaccine Doses Distributed in the United States
Summary:  View help for Summary Weekly Cumulative Influenza Vaccine Doses Distributed in the United States, 2016-2021 • Flu vaccine is produced by private manufacturers. For the 2020-2021 season, manufacturers have projected they will provide as many as 194 to 198 million doses of influenza vaccine for the U.S. market. • Additional information is available: https://www.cdc.gov/flu/prevent/vaccine-supply-distribution.htm. Read less
Original Distribution URL:  View help for Original Distribution URL https://data.cdc.gov/Vaccinations/Weekly-Cumulative-Influenza-Vaccine-Doses-Distribu/e5zk-7tx5/about_data

Scope of Project

Subject Terms:  View help for Subject Terms influenza; flu; flu vaccination
Collection Notes:  View help for Collection Notes (Downloaded 1/12/2026)


Related Publications

Download this file

Published Versions

V1 [2026-01-12]

Export Metadata

Dublin Core

DDI 2.5

Report a Problem

Found a serious problem with the data, such as disclosure risk or copyrighted content? Let us know.

This material is distributed exactly as received from the data depositor. ICPSR has not reviewed, checked, or processed this material. For additional information about the study, please contact the investigator(s) directly. If you have questions about the accessibility of materials distributed by ICPSR or require further assistance, please visit ICPSR's Accessibility Center.